Diverse genomic and transcriptomic heterogeneity in EGFR-mutant lung adenocarcinoma between exon 19 del and exon 21 L858R - PubMed
5 hours ago
- #Genomic Heterogeneity
- #EGFR
- #Lung Adenocarcinoma
- Study focuses on genomic and transcriptomic heterogeneity in EGFR-mutant lung adenocarcinoma between exon 19 del and exon 21 L858R.
- Ethics approval obtained from Sun Yat-sen University Cancer Center with informed consent from all participants.
- No competing interests declared by the authors.
- References include key studies on EGFR mutations in lung cancer.
- Funding sources include National Science and Technology Major Project and Chinese National Natural Science Foundation.